Nature of Business (Details)							3 Months Ended		6 Months Ended
	Aug. 14, 2023 USD ($) $ / shares shares	May 09, 2023 USD ($) $ / shares shares	May 02, 2023 $ / shares shares	Apr. 27, 2023 shares	Feb. 10, 2023	Feb. 09, 2023 shares	Jun. 30, 2023 USD ($) shares	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($) segment shares	Jun. 30, 2022 USD ($)	Dec. 31, 2022 USD ($) shares	Dec. 31, 2021 USD ($)
Nature of business:
Number of operating segments | segment									2
Accumulated deficit							$ (222,221,579)		$ (222,221,579)		$ (219,563,446)
Net loss							(1,612,024)	$ (2,386,760)	(2,658,133)	$ (6,735,781)
Net cash used in operating activities									(4,089,580)	(5,766,903)
Reclassification of convertible debt from current to non-current liability							2,094,000		2,094,000
Number of shares sold							3,020,732		3,091,462
Cash and cash equivalents							13,160,939	20,157,692	13,160,939	20,157,692	13,359,615	$ 26,043,897
Net decrease in cash									$ 198,676	5,886,205
Percentage change in cash and cash equivalent									1.00%
Accumulated deficit							222,221,579		$ 222,221,579		219,563,446
Working capital							7,713,536		7,713,536		(2,663,721)
Working capital increase, decrease									$ (10,377,257)
Working capital increase (decrease) as a percent									390.00%
Government grant funding							$ 113,756		$ 113,756		$ 115,130
Common Stock, Shares, Issued | shares							9,841,854		9,841,854		2,908,578
Number of shares issued | shares				50,000
Reverse stock spilt effective from February 10, 2023					0.067	0.067
Fractional shares issue under reverse stock split | shares						0
Repayment of debt principal									$ 7,000,000
Consideration paid recorded in general and administrative expense							$ 890,533	$ 1,382,793	2,125,909	$ 3,924,261
Issuance of common stock in connection with Silk Roads purchase option							50,000		50,000
Public Offering
Nature of business:
Proceeds from Issuance of Common Stock		$ 8,500,000
Shares issued price per share | $ / shares		$ 1.30
Exercise price of warrants | $ / shares		$ 0.001
Expiration term of warrants		5 years
B. Riley Sales Agreement
Nature of business:
Proceeds from Issuance of Common Stock									7,700,000
Number of shares sold									3,000,000
Common Stock
Nature of business:
Number of shares sold							$ 830		$ 851
Issuance of common stock in connection with Silk Roads purchase option (in shares) | shares							31,646		31,646
Issuance of common stock in connection with Silk Roads purchase option							$ 32		$ 32
Common Stock | Public Offering
Nature of business:
Shares issued price per share | $ / shares		$ 1.30
Number of shares issued | shares		2,301,500
Exercise price of warrants | $ / shares		$ 1.50
Pre-funded warrants | Public Offering
Nature of business:
Number of common warrants to purchase shares issued | shares		4,237,000
Common warrants | Public Offering
Nature of business:
Number of common warrants to purchase shares issued | shares		6,538,500
Exercise price of warrants | $ / shares		$ 1.50
CiVax
Nature of business:
Revenue from collaborative arrangement									$ 1,500,000
Term (in years)									P2Y
HyBryte
Nature of business:
Revenue from collaborative arrangement									$ 1,100,000
Term (in years)									P4Y
NIH
Nature of business:
Government grant funding							1,100,000		$ 1,100,000
Exclusive option agreement | Silk Road
Nature of business:
Consideration paid recorded in general and administrative expense							$ 50,000		$ 50,000
Exclusive option agreement | Common Stock
Nature of business:
Shares issued price per share | $ / shares			$ 1.58
Number of shares issued | shares			31,646
Exclusive option agreement | Common Stock | Silk Road
Nature of business:
Issuance of common stock in connection with Silk Roads purchase option (in shares) | shares							31,646		31,646
Issuance of common stock in connection with Silk Roads purchase option							$ 50,000		$ 50,000
B Riley Sales Agreement [Member] | Underwritten public offering
Nature of business:
Maximum Percentage Of Shares Available For Sale Of Market Value	33.33%
B Riley Sales Agreement [Member] | Subsequent Event
Nature of business:
Proceeds from Issuance of Common Stock	$ 3,091,462
Common stock available for sale (in Dollars)	$ 23,600,000
Maximum Percentage Of Shares Available For Sale Of Market Value	33.33%
Shares issued price per share | $ / shares	$ 3.63
Common Stock, Shares, Issued | shares	851,130